Advanced search
Publication Cover
Research and Reports in Urology Volume 13, 2021 - Issue
Submit an article Journal homepage
222
Views
1
CrossRef citations to date
0
Altmetric
Clinical Trial Report

A Randomized, Single-Blinded Clinical Trial Evaluating the Effect of Extracorporeal Shockwave Treatment (ESWT) as Add-On Therapy to Vacuum Erectile Device on Peyronie’s Disease

Jonas Mortensen1 Department of Urology, Odense University Hospital, Odense, DenmarkCorrespondence[email protected]
View further author information
,
Sune Møller Skov-Jeppesen1 Department of Urology, Odense University Hospital, Odense, Denmark;2 Institute of Clinical Research, University of Southern Denmark, Odense, DenmarkView further author information
,
Peter Bill Juul Ladegaard1 Department of Urology, Odense University Hospital, Odense, DenmarkView further author information
&
Lars Lund1 Department of Urology, Odense University Hospital, Odense, Denmark;2 Institute of Clinical Research, University of Southern Denmark, Odense, DenmarkView further author information
Pages 715-722 | Published online: 16 Sep 2021

References

  • Campbell J, Alzubaidi R. Understanding the cellular basis and pathophysiology of Peyronie’s disease to optimize treatment for erectile dysfunction. Transl Androl Urol. 2017;6(1):46–59. doi:10.21037/tau.2016.11.01
  • Ostrowski KA, Gannon JR, Walsh TJ. A review of the epidemiology and treatment of Peyronie’s disease. Res Rep Urol. 2016;8:61–70.
  • Ralph D, Gonzalez-Cadavid N, Mirone V, et al. The management of Peyronie’s disease: evidence-based 2010 guidelines. J Sex Med. 2010;7(7):2359–2374. doi:10.1111/j.1743-6109.2010.01850.x
  • Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U. The prevalence of Peyronie’s disease: results of a large survey. BJU Int. 2001;88(7):727–730. doi:10.1046/j.1464-4096.2001.02436.x
  • Mulhall JP, Creech SD, Boorjian SA, et al. Subjective and objective analysis of the prevalence of Peyronie’s disease in a population of men presenting for prostate cancer screening. J Urol. 2004;171(6 Part 1):2350–2353. doi:10.1097/01.ju.0000127744.18878.f1
  • Al-Thakafi S, Al-Hathal N. Peyronie’s disease: a literature review on epidemiology, genetics, pathophysiology, diagnosis and work-up. Transl Androl Urol. 2016;5(3):280–289. doi:10.21037/tau.2016.04.05
  • Mittermayr R, Antonic V, Hartinger J, et al. Extracorporeal shock wave therapy (ESWT) for wound healing: technology, mechanisms, and clinical efficacy. Wound Repair Regen. 2012;20(4):456–465.
  • Hatzimouratidis K, Eardley I, Giuliano F, et al. EAU guidelines on penile curvature. Eur Urol. 2012;62(3):543–552. doi:10.1016/j.eururo.2012.05.040
  • Cui HS, Hong AR, Kim JB, et al. Extracorporeal shock wave therapy alters the expression of fibrosis-related molecules in fibroblast derived from human hypertrophic scar. Int J Mol Sci. 2018;19(1):124. doi:10.3390/ijms19010124
  • Fojecki GL, Tiessen S, Osther PJS. Extracorporeal shock wave therapy (ESWT) in urology: a systematic review of outcome in Peyronie’s disease, erectile dysfunction and chronic pelvic pain. World J Urol. 2017;35(1):1–9. doi:10.1007/s00345-016-1834-2
  • Rosen RC, Cappelleri JC, Gendrano N. The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res. 2002;14:226. doi:10.1038/sj.ijir.3900857
  • Coyne Karin S, Currie Brooke M, Thompson Christine L, Smith Ted M. Responsiveness of the Peyronie’s disease questionnaire (PDQ). J Sex Med. 2015;12(4):1072–1079. doi:10.1111/jsm.12838
  • Ferreira-Valente MA, Pais-Ribeiro JL, Jensen MP. Validity of four pain intensity rating scales. Pain. 2011;10:2399–2404.
  • Hellstrom WJG, Feldman R, Rosen RC, Smith T, Kaufman G, Tursi J. Bother and distress associated with Peyronie’s disease: validation of the Peyronie’s disease questionnaire. J Urol. 2013;190(2):627–634. doi:10.1016/j.juro.2013.01.090
  • Raheem Amr A, Garaffa G, Raheem Tarek A, et al. The role of vacuum pump therapy to mechanically straighten the penis in Peyronie’s disease. BJU Int. 2010;106(8):1178–1180. doi:10.1111/j.1464-410X.2010.09365.x
  • Seftel AD. Re: safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie’s disease using a new modified shortened protocol. J Urol. 2017;198(6):1193.
  • Avant RA, Ziegelmann M, Nehra A, Alom M, Kohler T, Trost L. Penile traction therapy and vacuum erection devices in Peyronie’s disease. Sex Med Rev. 2019;7:338–348. doi:10.1016/j.sxmr.2018.02.005
  • Lu Z, Lin G, Reed-Maldonado A, Wang C, Lee YC, Lue TF. Low-intensity extracorporeal shock wave treatment improves erectile function: a systematic review and meta-analysis. Eur Urol. 2017;71(2):223–233. doi:10.1016/j.eururo.2016.05.050
  • Hatzichristodoulou G, Meisner C, Gschwend Jürgen E, Stenzl A, Lahme S. Extracorporeal shock wave therapy in Peyronie’s disease: results of a placebo‐controlled, prospective, randomized, single‐blind study. J Sex Med. 2013;10(11):2815–2821. doi:10.1111/jsm.12275
  • Palmieri A, Imbimbo C, Longo N, et al. A first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie’s disease. Eur Urol. 2009;56(2):363–370. doi:10.1016/j.eururo.2009.05.012

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.